PAR paradigm biopharmaceuticals limited..

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-65

  1. 6,621 Posts.
    lightbulb Created with Sketch. 1291
    agreed.... well, actually, i think the market has put a price on trust... but, i do fear that the constant promotion by the CEO of RAC could set the market cap up for a pummelling when things get tough and delays etc... by no means guaranteed and could be completely wrong... but, seen it here and IMU... large market caps that probably got ahead of themselves through promotion and promise... that didn't eventuate....well at least yet.

    definitely not straight comparison of apples with apples i know, just the fear i have when everyone drools over the ceo's commentary... been there, experienced that.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $116.8M
Open High Low Value Volume
30.0¢ 30.5¢ 29.5¢ $56.35K 188.1K

Buyers (Bids)

No. Vol. Price($)
1 9339 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 14285 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.